13th Jun 2025, Visakhapatnam : ICICI Bank has announced that it has started construction work on a new building at the Homi Baba Cancer Hospital and Research Centre (HBCHRC) in Visakhapatnam, Andhra Pradesh, in association with Tata Memorial Centre (TMC). f6x2h
ICICI Bank is providing funds with a commitment of over Rs. 550 crore for the construction of this state-of-the-art center, which will be spread over an area of approximately 3.9 lakh sq. ft. and equipped with the latest medical technology.
The new eight-storey ICICI Foundation Block for Child and Blood Cancer building, once completed, will be able to serve 3,000 patients annually. The current annual capacity of HBCHRC in Visakhapatnam is 6,200 patients.
The new building, which is being designed to be one of the best specialized cancer treatment centers in Eastern India, will have over 215 beds. It is expected to be completed by 2027, subject to all approvals. ICICI Foundation for Inclusive Growth, the CSR arm of ICICI Bank, will oversee its implementation.
ICICI Bank Chairman Mr. Pradeep Kumar Sinha unveiled the foundation stone of the new building in the presence of Mr. Sandeep Batra, Executive Director, ICICI Bank, and Dr. Sudeep Gupta, Director, Tata Memorial Centre (Mumbai).
Mr. Sinha also inaugurated the NK Rao Auditorium in the presence of other dignitaries. ICICI Foundation has provided assistance to TMC in of infrastructure and equipment for the new auditorium.
“We are proud to hands with TMC in cancer care in line with our vision to strengthen the country’s critical healthcare infrastructure. This project is a testament to our commitment to provide the highest quality medical care to the needy. It will also be one of the largest projects in the Eastern Corridor for pediatric and hematological cancers. It will serve patients in Andhra Pradesh and the ading eastern states. It will help meet the growing cancer treatment needs,” said Mr. Pradeep Kumar Sinha, Chairman, ICICI Bank.
“ICICI Bank has a special focus on healthcare as part of its CSR activities. Two years ago, we partnered with TMC, a leading provider of cancer care in India, by committing Rs. 1,200 crore to set up three new TMC centres in Visakhapatnam, Navi Mumbai and New Chandigarh. We are pleased to announce that we are increasing this amount to Rs. 1,800 crore in view of TMC’s latest requirements. These new blocks, spread over 10.7 lakh sq ft, will house state-of-the-art medical facilities and research departments. These blocks will have a total of 19 LINACs* and 555 beds. Once fully operational, they will act as regional hubs,” said Mr. Sandeep Batra, Executive Director, ICICI Bank .
“Thank you to ICICI Foundation for its generosity. This will significantly contribute to the advancement of pediatric and hematolymphoid cancer treatment and research in the region. Our partnership with ICICI Foundation is a testament to the collective efforts of our institutions to provide the best treatment and achieve better outcomes for cancer patients across the country,” said Dr. Umesh Mahantshetty , Director, Homi Baba Cancer Hospital and Research Center, Visakhapatnam .
“Pediatric & Hematolymphoid Cancers require specialized care in of diagnostic tests, evaluation, treatment, as well as services and skills like blood center, nutrition, rehabilitation. HBCHRC, Visakhapatnam, has been ing around 200 new pediatric cancer patients and 350-400 hematolymphoid cancer patients daily for the last three years. This new block will help in significantly expanding the existing services along with the bone marrow transplant program and also introducing immunotherapy. It will also provide significant scope for conducting research related to patients regionally,” said Dr. Girish Chinnaswamy, Professor & Head, Tata Memorial Hospital, Mumbai.
The Rs. 550 crore donation to the Visakhapatnam hospital will be part of the Rs. 1,800 crore donation to be made by ICICI Bank.
The following comprehensive treatment services are available at ICICI Foundation Child and Blood Cancer Block in Visakhapatnam:
- Intensive chemotherapy, bone marrow transplantation, advanced radiation therapy
- Advanced immunotherapies like CAR-T cell therapy
- The most advanced medical imaging and diagnostics, including three LINACs*, MRI and CVT-PET scans
- 14 BMT (Bone Marrow Transplant) rooms, 14 ICUs, 5 Operating Theatres
- Laboratories for research, t discussion centers for treatment planning and training
- Linear accelerators (LINACs) precisely target radiation to cancer cells, sparing nearby healthy tissue.
Be the first to comment 3t5h3u